Ruthenium(II) complexes containing bidentate Schiff bases and triphenylphosphine or triphenylarsine

Reactions of ruthenium(II) complexes [RuHX(CO)(EPh₃)₂(B)] (X = H or Cl; B = EPh₃, pyridine (py) or piperidine (pip); E = P or As) with bidentate Schiff base ligands derived by condensingo- hydroxyacetophenone with aniline,o- orp-methylaniline have been carried out. The products were characterized by analytical, IR, electronic and¹H-NMR spectral studies and are formulated as [Ru(X)(CO) (L)(EPh₃)(B)] (L = Schiff base anion; X = H or Cl; B = EPh₃, py or pip; E = P or As). An octahedral structure has been tentatively proposed for the new complexes. The new complexes were tested for their catalytic activities in the oxidation of benzyl alcohol to benzaldehyde.     

Synthesis,characterization and biological properties of novel ON donor bidentate Schiff bases and their copper(II) complexes

Four novel ON donor Schiff bases (E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol (HL₁),(E)-3-((4-(4-biphenyloxy)phenyliminomethyl)benzene-1,2-diol (HL₂), (E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol (HL₃), (E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol (HL₄) and their copper(II) complexes bis((E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₁)₂) bis((E)-3-((4-(4-biphenyloxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₂)₂), bis((E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₃)₂), bis((E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₄)₂) have been synthesized and characterized by spectroscopic (FTIR, NMR, UV–visible) and elemental analysis. The crystal structures of HL₁, HL₂, HL_3, and HL₄ have been determined, which reveal intramolecular N-H?O (HL₁, HL₂, HL_3, and HL₄) hydrogen bonds in the solid state. Keto-amine and enol-imine tautomerism is exhibited by the Schiff bases in solid and solution states. The Schiff bases and their copper(II) complexes have been screened for their biological activities. In antimicrobial assays (antibacterial and antifungal), HL₄ showed promising results against all strains through dual inhibition property while the rest of the compounds showed activity against selective strains. On the other hand, in cytotoxic, DPPH, and inhibition of hydroxyl (OH) free radical-induced DNA damage assays, the results were found significantly correlated with each other, i.e. the ligands HL₁ and HL₂ showed moderate activity while their complexes Cu(L₁)₂ and Cu(L₂)₂ exhibited prominent increase in activity. As the results of these assays are supporting each other, it represents the strong positive correlation and antioxidant nature of investigated compounds.     

Synthesis,characterization, and electrochemical study of two new macroacyclic Schiff bases and their copper(II) and zinc(II) complexes

Two new potentially octadentate N₂O₆ Schiff-base ligands 2-((E)-(2-(2-(2-((E)-2-hydroxy-3-methoxybenzylideneamino)phenoxy)phenoxy)phenylimino)methyl)-6-methoxyphenol H₂L¹ and 2-((E)-(2-(2-(2-((E)-2-hydroxy-3-methoxybenzylideneamino)phenoxy)-4-tert-butylphenoxy)phenylimino)methyl)-6-methoxyphenol H₂L² were prepared from the reaction of O-Vaniline with 1,2-bis(2′-aminophenoxy)benzene or 1,2-bis(2′-aminophenoxy)-4-t-butylbenzene, respectively. Reactions of H₂L¹ and H₂L² with copper(II) and zinc(II) salts in methanol in the presence of N(Et)₃ gave neutral [CuL¹]?·?0.5CH₂Cl₂, [CuL²], [ZnL¹]?·?0.5CH₂Cl₂, and [ZnL²] complexes. The complexes were characterized by IR spectra, elemental analysis, magnetic susceptibility, ESI–MS spectra, molar conductance (Λ_m), UV-Vis spectra and, in the case of [ZnL¹]?·?0.5CH₂Cl₂ and [ZnL²], with ¹H- and ¹³C-NMR. The crystal structure of [ZnL¹]?·?0.5CH₂Cl₂ has also been determined showing the metal ion in a highly distorted trigonal bipyramidal geometry. The electrochemical behavior of H₂L² and its Cu(II) complex, [CuL²], was studied and the formation constant of [CuL²] was evaluated using cyclic voltammetry. The logarithm value of formation constant of [CuL²] is 21.9.     

The structures and cyclic voltammetry of three copper(II) complexes derived from bulky ortho-hydroxy Schiff bases

Three copper(II) complexes derived from bulky ortho-hydroxy Schiff base ligands, (1)-(3), were synthesized and characterized by chemical analysis, UV-Vis, IR, μ_eff and mass spectrometry. The solid state structures of compounds (1)-(3) were determined. The solid state X-ray diffraction studies of these compounds show that the geometry is intermediate between square planar and tetrahedral. Moreover, EPR studies in DMF solution at 77 K suggest that the geometry of these complexes in solution is different from that observed in the solid state by X-ray crystallography. Furthermore, cyclic voltammetry studies performed for (1)-(3), indicate a dependence of the cathodic potentials upon conformational and electronic effects.     

Synthesis,structural characterization,oxygen sensitivity,and antimicrobial activity of ruthenium(II) carbonyl complexes with thiosemicarbazones

[Ru(CO)(PPh₃)₂(η³-O,N³,S-TSC¹)] (1), [Ru(Cl)(CO)(PPh₃)₂(η²-N³,S-TSC²)] (2), and [Ru(Cl)(CO)(PPh₃)₂(η²-N³,S-TSC³)] (3) have been prepared by reacting [Ru(H)(Cl)(CO)(PPh₃)₃] with the respective thiosemicarbazones TSC¹ (2-hydroxy-3-methoxybenzaldehyde thiosemicarbazone), TSC² (3-hydroxybenzaldehyde thiosemicarbazone), and TSC³ (3,4-dihydroxybenzaldehyde thiosemicarbazone) in a 1?:?1 M ratio in toluene and all of the complexes have been characterized by UV–vis, FT-IR, and ¹H and ³¹P NMR spectroscopy. The spectroscopic studies showed that TSC¹ is coordinated to the central metal as a tridendate ligand coordinating via the azomethine nitrogen (C=N), phenolic oxygen, and sulfur to ruthenium in 1, whereas TSC² and TSC³ are coordinated to ruthenium as a bidentate ligand through azomethine nitrogen (C=N) and sulfur in 2 and 3. Oxygen sensitivities of 1–3 and [Ru(Cl)(CO)(PPh₃)₂(η²-N³,S-TSC⁴)] (4), and antimicrobial activities of 1–3 have been determined.     

Synthesis,spectral characterization and biological studies of transition metal(II) complexes with triazole Schiff bases

New metal based triazoles (1–12) have been synthesized by the interaction of novel Schiff base ligands (L¹–L³) with the Co(II), Ni(II), Cu(II) and Zn(II) metal ions. The Schiff base ligands and their all metal(II) complexes have been thoroughly characterized using various physical, analytical and spectroscopic techniques. In vitro bacterial and fungal inhibition studies were carried out to examine the antibacterial and antifungal profile of the Schiff bases in comparison to their metal(II) complexes against two Gram‐positive, four Gram‐negative and six fungal strains. The bioactivity data showed the metal(II) complexes to have more potent antibacterial and antifungal activity than their uncomplexed parent Schiff bases against one or more bacterial and fungal species. Copyright © 2012 John Wiley & Sons, Ltd.     

The crystal structures and electrochemical studies of two naphthalenic Schiff base copper(II) complexes

The Schiff base ligands, 2-hydroxy-N-cyclohexyl-l-naphthaldimine (I), and 3-hydroxy-N-cyclohexyl-2-naphthaldimine (II), and their corresponding Cu^II complexes (1–2) respectively were synthesized and characterized. The crystal and molecular structures of bis-{(cyclohexyl)[(2-oxo-1H-naphth-1-ylidene)-methyl]aminato}copper(II) (1) and bis-{(cyclohexyl)[(3-oxo-2H-naphth-2-ylidene)-methyl]aminato} copper(II) (2), were determined. The X-ray diffraction study shows that the geometry around the metal atom for (1), is stepped square planar with a step of 1.063 Å while for (2), the geometry around the metal atom for square planar with an angle between the coordination planes O(1)---Cu---N(1) and O(1a)---Cu---N(1a) of 39.9°. Electrochemical studies show a dependence of the Cu^II/Cu^I potentials on the ligand structure.     

Syntheses,characterization and X-ray crystal structures of Ni(II) complexes of tridentate monocondensed and tetradentate dicondensed Schiff bases

Two octahedral complexes [Ni(HL¹)₂](ClO₄)₂ (1) and [Ni(HL²)₂](ClO₄)₂ (2) and a square planar complex [Ni(HL³)]ClO₄ (3) have been prepared, where [HL¹ = 3-(2-amino-ethylimino)-butan-2-one oxime, HL² = 3-(2-amino-propylimino)butan-2-one oxime] and H₂L³ = 3-[2-(3-hydroxy-1-methyl-but-2-enylideneamino)-1-methyl-ethylimino]-butan-2-one oxime. All the complexes have been characterized by elemental analyses, spectral studies and room temperature magnetic moment measurements. The molecular structures of all three compounds were elucidated on the basis of X-ray crystallography; complexes 1 and 2 are seen to be the mer isomers.     

Synthesis,crystal structures and spectral studies of square planar nickel(II) complexes containing an ONS donor Schiff base and triphenylphosphine

Five mononuclear nickel(II) complexes, viz. [Ni(L1)(PPh₃)] (1), [Ni(L2)(PPh₃)] (2), [Ni(L3)(PPh₃)] (3), [Ni(L4)(PPh₃)] (4) and [Ni(L5)(PPh₃)] (5) (where L1, L2, L3, L4 and L5 are dianions of N-(2-mercaptophenyl)salicylideneimine, 5-methyl-N-(2-mercaptophenyl)salicylideneimine, 5-chloro-N-(2-mercaptophenyl)salicylideneimine, 5-bromo-N-(2-mercaptophenyl)salicylideneimine and N-(2-mercaptophenyl)naphthylideneimine, respectively), have been synthesized and characterized by means of elemental analysis, electronic, IR, ¹H, ¹³C and ³¹P NMR spectroscopy. Single crystal X-ray analysis of two of the complexes (1 and 5) has revealed the presence of a square planar coordination geometry (ONSP) about nickel. The crystal structures of the complexes are stabilized by intermolecular π–π stacking between the ligands (L) and by various C–H···π interactions.     

Spectral characterization,electrochemical, antimicrobial and cytotoxic studies on new metal(II) complexes containing N2O4 donor hexadentate Schiff base ligand

We report the biological activity of the new Schiff base ligand H₂L (H₂L = 6,6′-((1E,11E)-5,8-dioxa-2,11-diazadodeca-1,11-diene-1,12-diyl)bis(2,4-dichlorophenol)), its derived metal(II) complexes [Cu(L)] (1), [Co(L)] (2), [Ni(L)] (3) and [Zn(L)] (4), along with their structural characterizations by using various analytical and spectroscopic techniques. Electrochemical investigations showed that all of these Cu(II), Co(II) and Ni(II) complexes were reversibly reducible. Although the change of the number of unpaired electrons are different of the metal cations, they have an effect on the redox potentials of the Co(II)/(I), Ni(II)/(I) and Cu(II)/(I) couples. The ¹H NMR and FTIR data concluded that the Schiff base ligand H₂L acts as a hexadentate ligand coordinating with metal(II) ions through the oxygen atoms of the (COC), phenolic (COH) groups and nitrogen atom of the azomethine (CHN) group. UV-Visible absorption spectra studies clearly revealed the octahedral geometry of the prepared metal(II) complexes. Complexes 1 and 4 were found to be efficient in bringing about antimicrobial activities. The proposed mechanism of their antimicrobial activities has been discussed. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay showed the remarkable cytotoxicity of complex 1 (IC50 = 17 ± 1.3 μg/mL) on human breast cancer MCF-7 cells than Schiff base ligand H₂L and complexes 2–4. Moreover, AO/EB staining assay revealed cell death due to apoptosis in MCF-7 cells and the generation of ROS by the Schiff base ligand H₂L and its derived metal(II) complexes 1–4 may be a possible cause for their cytotoxic activity.     

Synthesis,spectral, and catalytic studies of ruthenium(II) unsymmetrical Schiff-base complexes

Unsymmetrically-substituted ruthenium(II) Schiff-base complexes, [Ru(CO)(B)(L ^x )] [B = PPh₃, AsPh₃ or Py; L ^x = dianion of tetradentate unsymmetrical Schiff-base ligand; x = 4–7, L⁴ = salen-o-hyac, L⁵ = valen-o-hyac, L⁶ = salphen-o-hyac, L⁷ = valen-2-hacn], were prepared and characterized by analytical, IR, electronic, and ¹H NMR spectral studies. The new complexes were tested for their catalytic activity towards the oxidation of benzylalcohol to benzaldehyde.     

Synthesis,characterization and cytotoxicity of platinum(II) complexes containing reduced amino acid ester Schiff bases

Nine platinum(II) complexes containing reduced amino acid ester Schiff bases were synthesized and characterized using spectroscopy (¹H NMR, ¹³C NMR, infrared), elemental analysis and molar conductivity. The interaction of these complexes with salmon sperm DNA was investigated by means of ultraviolet and circular dichroism spectroscopies. The potential antitumor activity of all compounds was tested in vitro on HeLa and A549 tumor cell lines. Almost all the complexes exhibited better cytotoxic activity than cisplatin against these cell lines.     

Tetradentate asymmetric Schiff bases and their Ni(II) and Fe(III) complexes

Three asymmetric Schiff-base tetradentate diimines H₂L¹, H₂L², and H₂L³ [(2-OH)C₆H₄N=CHC₆H₄2-N=CHC₆H₃(2-OH)(5-X), X?=?H, CH₃, Cl respectively] have been synthesized by a two step process. The reaction of 2-hydroxy aniline with 2-nitro-benzaldehyde in EtOH gave the starting Schiff base, 2-hydroxy-N-(2-nitrobenzylidene)aniline (SB-NO₂), which was reduced into the amino derivative (SB-NH₂) in solution. Reacting SB-NH₂ with 2-hydroxybenzaldehyde, 2-hydroxy-5-methylbenzaldehyde and 2-hydroxy-5-chlorobenzaldehyde gave the three new ligands H₂L¹, H₂L², and H₂L³ respectively. Their dimeric, binuclear metal complexes with Ni(II) and Fe(III) have also been synthesized. The ligands and their complexes were characterized by elemental analyses, LC–MS, IR, electronic, ¹H and ¹³C-NMR spectra, TGA, conductivity and magnetic measurements. All of the spectroscopic, analytical and other data indicate octahedral geometry M₂L₂(H₂O)X₂ (M: Ni,Co;X: Cl or H₂O), except for NiL² which is monomeric. Antimicrobial activities of the ligands and the complexes were evaluated against five bacteria. While the ligands and the Ni complexes are inactive towards Pseudomonas aeruginosa and Staphylococcus aureus, Fe complexes are active; only Fe complexes are inactive against Escherichia coli. All of the compounds have antimicrobial activities against Bacillus subtilis, and Yersinia enterecolitica.     

Ruthenium(II) unsymmetrical N2O2 tetradentate Schiff-base complexes: synthesis,characterization, and catalytic studies

A series of six-coordinate ruthenium(II) complexes [Ru(CO)(L ^x )(B)] (B = PPh₃, AsPh₃ or Py; L ^x = unsymmetrical tetradentate Schiff base, x = 5–8; L⁵= salen-2-hyna, L⁶= Cl-salen-2-hyna, L⁷= valen-2-hyna, L⁸= o-hyac-2-hyna) have been prepared by reacting [RuHCl(CO)(EPh₃)₂(B)] (E = P or As) with unsymmetrical Schiff bases in benzene under reflux. The new complexes have been characterized by analytical and spectroscopic (infrared, electronic, ¹H, ³¹P, and ¹³C NMR) data. An octahedral structure has been assigned for all the complexes. The new complexes are efficient catalysts for the transfer hydrogenation of ketones and also exhibit catalytic activity for the carbon–carbon coupling reactions.     

Synthesis,characterization, and in vitro antioxidant and anticancer studies of ruthenium(III) complexes of symmetric and asymmetric tetradentate Schiff bases

Ruthenium(III) complexes of three tetradentate Schiff bases with N₂O₂ donors formulated as [RuCl(LL¹)(H₂O)], [RuCl(LL²)(H₂O)] and [RuCl(LL³)(H₂O)] were synthesized and characterized by elemental analyses, molar conductance, FTIR, and electronic spectral measurements. The FTIR data showed that the tetradentate Schiff base ligands coordinate to Ru ions through the azomethine nitrogen and enolic oxygen. The antioxidant activities of the complexes were investigated through scavenging activity on 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS) radicals. The DPPH activity for [RuCl(LL²)(H₂O)] with IC₅₀ = 0.031 mg mL^?1 was higher than the values obtained for the other Ru(III) compounds. The study revealed that the synthesized Ru(III) complexes of the tetradentate Schiff base exhibited strong scavenging activities against DPPH and moderate against ABTS radicals. In addition, the antiproliferative studies of the complexes were also tested against human renal cancer cells (TK10), human melanoma cancer cells (UACC62), and human breast cancer cells (MCF7) using the SRB assay. The results indicated that the Ru(III) complexes showed low anticancer activities against the tested human cancer cell lines.     

Synthesis, structural characterization and electrochemical studies of new macrocyclic Schiff base containing pyridine head and its metal complexes

A new macrocyclic ligand, 1,3,5-triaza-2,4:7,8:13,14-tribenzo-9,12-dioksa-cyclopentadeca-1,5-diene was synthesized by reaction of 2,6-diaminopyridine and 1,2-bis(2-carboxyaldehyde phenoxy)ethane. Then, its Cu(II), Ni(II), Pb(II), Co(III) and La(III) complexes were synthesized by the template effect by the reaction of 2,6-diaminopyridine and 1,2-bis(2-carboxyaldehyde phenoxy)ethane and Cu(NO₃)₂ · 3H₂O, Ni(NO₃)₂ · 6H₂O, Pb(NO₃)₂, Co(NO₃)₂ · 6H₂O, La(NO₃)₃ · 6H₂O, respectively. The ligand and its metal complexes have been characterized by elemental analysis, IR, ¹H and ¹³C NMR, UV-Vis spectra, magnetic susceptibility, thermal gravimetric analysis, conductivity measurements, mass spectra, and cyclic voltammetry. All complexes are diamagnetic and Cu(II) complex is binuclear. The Co(II) was oxidized to Co(III). The comparative electrochemical studies show that the nickel complex exhibited a quasi-reversible one-electron reduction process, while copper and cobalt complexes gave irreversible reduction processes in DMSO solution.     

Synthesis and structural characterization of Ni(II) complexes containing a heterocyclic NO donor ligand

Five novel nickel(II) complexes have been successfully synthesized with a heterocyclic ligand, Opdac, [Ni(Opdac)₂]Cl₂ (1), [Ni(Opdac)₂(CH₃OH)₂]Br₂(CH₃OH)₂ (2), [Ni(Opdac)₂]I₂ (3), [Ni(Opdac)₂NO₃]NO₃ (4) and [Ni(Opdac)₂ClO₄]ClO₄ (5) where Opdac = 4-(1-H-1,3-benzimidazole-2-yl)-1,5-dimethyl-2-phenyl-1-2-dihydro-3-H-pyrazol-3-one. All the complexes were characterized by elemental analysis, molar conductivity, CHN analysis, magnetic susceptibility measurements, spectroscopic studies and TG/DTA methods. In all the complexes, Opdac acts as a bidentate ligand coordinating to Ni(II) ion via the benzimidazole imine nitrogen and the pyrazolone oxygen atoms. The complexes 1 and 3 have a tetrahedral geometry while 2, 4 and 5 have an octahedral geometry around the Ni(II) center.     

Synthesis,characterization, and antitumor properties of ruthenium(II) anthraquinone complexes

Three new Ru(II) complexes, [Ru(dmb)₂(ipad)](ClO₄)₂ (dmb = 4,4′-dimethyl-2,2′-bipyridine, ipad = 2-(anthracene-9,10-dione-2-yl) imidazo[4,5-f][1,10]phenanthroline, 1), [Ru(dmp)₂(ipad)](ClO₄)₂ (dmp = 2,9-dimethyl-1,10-phenanthroline, 2), and [Ru(dip)₂(ipad)](ClO₄)₂ (dip = 4,7-diphenyl-1,10-phenanthroline, 3), have been synthesized and characterized. The three Ru(II) complexes intercalate with the base pairs of DNA. The in vitro antiproliferative activities and apoptosis-inducing characteristics of these complexes were investigated. The complexes exhibited cytotoxicity against various human cancer cell lines. BEL-7402 cells displayed the highest sensitivity to 1, accounted for by the greatest cellular uptake. Complex 1 was shown to accumulate preferentially in the nuclei of BEL-7402 cells and cause DNA damage and induce apoptosis, which involved cell cycle arrest and reactive oxygen species generation.     

Mixed ligand Cu(II) complexes containing o-vanillin-l-tryptophan Schiff base and heterocyclic nitrogen bases: synthesis,structural characterization,and biological properties

[Cu(L)] (1) and mixed ligand copper(II) complexes [Cu(L)(A)] (2 and 3), where L is the Schiff base derived from o-vanillin and l-tryptophan and A is pyridine (2) and imidazole (3), were synthesized and characterized using conventional and spectral techniques. 2 was structurally characterized using single crystal X-ray crystallography showing that Cu(II) is coordinated through N₂O₂ donors in a square plane. The EPR spectra of the complexes in frozen solution support a square-based structure. Electrochemical behavior of the complexes has been studied by cyclic voltammetry. The DNA-binding properties of L and 1–3 with calf thymus DNA were investigated by spectral and kinetic methods. For all the complexes, the maximum value of binding constant (0.38 × 10⁶) was achieved with 3 by spectroscopic titration. The ability of compounds to break pUC19 DNA was checked by gel electrophoresis. The ligand and copper complexes exert cytotoxicity against MCF-7 cell line.